Fusion Fuel Green Hosts Third Quarter 2022 Investor Update
November 28, 2022 06:10 ET
|
Fusion Fuel Green Public Limited Company
SABUGO, Portugal, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) ("Fusion Fuel"), an emerging leader in the green hydrogen sector, today announced financial results for the...
VERB Publishes Management’s Prepared Remarks During Third Quarter 2022 Earnings Call
November 14, 2022 18:03 ET
|
Verb Technology Company, Inc.
$9 million in new gross proceeds from recent financings extends runway, $5 million of which from unsecured, non-dilutive, 18-month, non-convertible, 9% fixed interest loan;Massive cost-cutting...
VERB Files Third Quarter 10-Q
November 14, 2022 16:30 ET
|
Verb Technology Company, Inc.
Comprehensive Earnings Call Preview Highlights: $9 million in new gross proceeds from recent financings extends runway, $5 million of which from unsecured, non-dilutive, 18-month, non-convertible, 9%...
Nova Leap Health Corp. Posts Record Adjusted EBITDA for Third Quarter 2022
November 10, 2022 17:18 ET
|
Nova Leap Health Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or...
Inventiva publie ses informations financières du 3ème trimestre 2022¹
November 10, 2022 16:00 ET
|
INVENTIVA
Position de trésorerie2 à 72,6 M€ au 30 septembre 2021 , sans prise en compte du paiement de 12,6 M$ reçu le 4 novembre de la part de Sino BiopharmChiffre d’affaires de 0,1 M€ sur les neuf premiers...
Inventiva reports 2022 Third Quarter Financial Information¹
November 10, 2022 16:00 ET
|
INVENTIVA
Cash position2 at €72.6m as of September 30, 2022, not including the $12.6 million upfront payment received from Sino Biopharm on November 4, 2022Revenues of €0.1m for the first nine months of 2022 ...
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022 06:59 ET
|
Synlogic, Inc.
Top-line Phase 2 data for phenylketonuria (PKU) demonstrated robust plasma Phe reduction and high response rate; Phase 3 study initiation planned for H1 2023 Clinical readouts for SYNB1353 for...
Magnite Reports Third Quarter 2022 Results
November 09, 2022 16:05 ET
|
Magnite, Inc.
Total Revenue Grows 11% & Revenue ex-TAC Grows 12% Year-Over-Year CTV Revenue ex-TAC Grew 29% Year-Over-Year & Represents 44% of Total Adjusted EBITDA Margin of 35% NEW YORK, Nov. 09, 2022...
VERB to Host Third Quarter 2022 Earnings Call on Monday, November 14, 2022, at 5:30 p.m. ET
November 09, 2022 13:55 ET
|
Verb Technology Company, Inc.
NEWPORT BEACH, Calif. and SALT LAKE CITY, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales...
NEURONES: Organic growth up 14.7% in 3rd quarter 2022
November 09, 2022 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 3rd quarter 2022 revenues Nanterre, November 9, 2022 (after trading) Organic growth up 14.7% in 3rd quarter 2022 (not audited, in € millions)20212022 growth of which...